In China, Israel, Mexico, Singapore and Sri Lanka
Suven Life Sciences announced the the grant of one (1) product patent from China (CN 102869647), one (1) product patent from Israel (220709), one (1) product patent from Mexico (329382), one (1) product patent from Singapore (181992) and one (1) product patent from Sri Lanka (15412) corresponding to their New Chemical Entities (NCEs) for the treatment of disorders associated with Neurodegenerative diseases.The granted claims of the patents include the class of selective 5-HT compounds discovered by Suven and are being developed as therapeutic agents and are useful in the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer's disease, Attention deficient hyperactivity disorder (ADHD), Huntington's disease, Parkinson and Schizophrenia.
Powered by Capital Market - Live News